DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

US Market Access Commercial Strategy

For over fifteen years, DRGC has served as a strategic thought partner for biopharmaceutical and medtech clients looking to develop and optimize their US market access commercial strategy.

DRGC's expertise in this area comes from having successfully completed 1,000+ engagements in this space, with about 150+ projects completed annually in the areas of pricing, reimbursement and market access.

 

a13

 

 

Best-in-class consulting

DRGC is able to leverage best-in-class consulting services when partnering with our clients to address comprehensive or targeted business objectives related to their US market access commercial strategy. This may range from providing full-scale support in the development and implementation of market access strategy and tactical plans for launch brands, to addressing focused business issues related to pricing, reimbursement and contract strategy for established products.

Proprietary data

In addition to in-house market access expertise, DRGC is able to harness the full breadth of internal DRG proprietary content assets and data sets to enrich insight generation and strategy development.

 

 

Capabilities include:

  • Strategy & tactical plan development
  • Pricing, reimbursement & contract strategy
  • Buying process & stakeholder mapping
  • Channel strategy
  • Customer segmentation